Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-04 · accession 0001209191-22-023237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-05 | 2022-04-04 | TVRD | Posner Christopher | Pres, CEO, Dir | S - Sale | $12.67 | -2,006 | 201.0K | -1.0% | -$25.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-04 | S | D | 2,006 | $12.67 | 201,031 | D | — | — |